The laboratory community needs your help to delay the Centers for Medicare and Medicaid Services (CMS) from implementing new payment rates for the Medicare Clinical Laboratory Fee Schedule (CLFS).
In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to base Medicare CLFS reimbursement rates on laboratory-reported private market rates. Unfortunately, current Medicare rules exclude 95 percent of clinical laboratories, including most physician office and hospital laboratories, from reporting their private market rates. ASCP is concerned that many of the CLFS payment rates may be underpriced relative to the true market rate.
ASCP is asking you to contact your Members of Congress and ask them to urge CMS to delay PAMA implementation until CMS can develop CLFS rates that factor in the full laboratory market and are truly market-based. Learn more and contact your Members of Congress here.